The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety
Open Access
- 9 January 2016
- journal article
- research article
- Published by Springer Nature in Familial Cancer
- Vol. 15 (2) , 155-162
Abstract
Background: Predictive genetic testing has high impact on cancer prevention for BRCA carriers and passing this information in BRCA families is important. Mostly, this is proband-mediated but this path is defective and denies relatives lifesaving information. Objective: To assess the efficacy/safety of an intervention, in which relatives are actively informed. Design: Sequential prospective study in new BRCA families. The proband informed relatives about predictive testing (phase I). After 6 months, a letter was sent to adult relatives who had not been reached (phase II). Then a phone call was made to obtain a final notion of their wishes. All subjects received psychometric testing (State-Trait Anxiety Inventory, STAI), an interview and routine counselling. Results: Twenty families were included. Twenty-four of the relatives could not be reached, 59 were ‘decliners’, 47 participated by the proband and 42 by the letter. Predictive testing was performed in 98 % of the participants of which 30 were mutation carriers. The intervention is psychologically safe: the 95 % CI for the estimated mean difference in STAI DY1 between phase II/I subjects (mean difference −1.07, 95 % CI −4.4 to 2.35, p = 0.53) shows that the mean STAI DY1 score (measured at first consult) for phase II is no more than 2.35 units higher than for phase I, which is not relevant. Conclusions: A protocol directly informing relatives nearly doubles the number of relatives tested and is psychologically safe. This should lead to a change in counselling guidelines in families with a strong germline predisposition for cancer.Keywords
This publication has 21 references indexed in Scilit:
- Comparison of proactive and usual approaches to offering predictive testing for BRCA1/2 mutations in unaffected relativesClinical Genetics, 2009
- Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndromeBMC Cancer, 2008
- Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testingJournal of Medical Genetics, 2007
- Prophylactic Mastectomy in BRCA1/2 Mutation Carriers and Women at Risk of Hereditary Breast Cancer: Long-Term Experiences at the Rotterdam Family Cancer ClinicAnnals of Surgical Oncology, 2007
- Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancerHuman Reproduction, 2007
- Meta-Analysis of BRCA1 and BRCA2 PenetranceJournal of Clinical Oncology, 2007
- Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorderJournal of Medical Genetics, 2006
- Ethical Obligations and Counseling Challenges in Cancer GeneticsJournal of the National Comprehensive Cancer Network, 2006
- Hereditary breast and ovarian cancer: review and future perspectivesJournal of Molecular Medicine, 2005
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesThe American Journal of Human Genetics, 2003